中文

Increase the probability of your
products' success
dMed + Clinipace
Together as One

News & Events

Drug Registration Environment in China and dMed / Clinipace Regulatory Affairs & Strategy Services2021-07-26

The drug regulatory environment and regulatory supporting measures (including laws, regulations, rules, and guidance, etc.) in China have undergone historic changes in the past decade. Since 2015, the ...

Read More

dMed-Clinipace Announces Completion of US$50 Million Series C+ Financing from New Investors2021-07-07

Shanghai, China, and Morrisville, N.C., USA, July 7th, 2021—dMed-Clinipace, the global full-service Clinical Contract Research Organization (CRO), announced today the recent successful completion of a ...

Read More

Generalized strategy for early clinical development – integrated scientific and operation solutions2021-05-25

At 2021 DIA China Annual Meeting, Dr. Jun Shi systematically elaborated eight main strategies for accelerating clinical development in the early clinical development stage, and proposed that under the ...

Read More

Recently Merged dMed and Clinipace Announce the Appointment of New Global COO2021-05-21

Simon Britton, a 30-year industry veteran with extensive global experience growing clinical development services and capabilities, will oversee the combined company’s operations.

Read More

CROs dMed and Clinipace Merge to Accelerate Customer Success2021-04-28

The combined Company will provide full-service CRO services to meet needs of global fast-moving biotech, pharma and medical device companies, and to accelerate the delivery of innovative solutions to p...

Read More

Innoforce and dMed Collaborate to Accelerate the Development of Innovative Therapeutics2021-03-02

Innoforce, a biopharmaceutical innovation enabling platform and PDMO (Partner Development and Manufacturing Organization), and dMed, a clinical CRO with strong presence in China and the US - the world’...

Read More

dMed Completed a US$100 Million Series C Financing2020-12-17

Shanghai, China, Dec. 17th , 2020-- dMed, the clinical CRO with strong presence in China and the US, the world’s two largest pharmaceutical markets and drug development sites, announced today its succe...

Read More

Genetron Health and dMed Announce Partnership Agreement2020-09-17

BEIJING, September 16, 2020 – Genetron Holdings Limited (“Genetron Health” or the “Company”) (Nasdaq: GTH), a leading precision oncology company in China that specializes in offering molecular profilin...

Read More

China:
298 Xiangke Road, 3/F, 301-305, Pudong New District, Shanghai 201210
Tel: +86 21 5090 0085 Fax: +86 21 6875 5515

United States:
3800 Paramount Pkwy, Suite 100 Morrisville, NC 27560
Tel: +1 919-224-8800

沪ICP备16041651号 Copyright © 2016-2021 dMed All Rights Reserved
沪公网安备 31011502005403号